New understanding about the pathophysiology of the condition, along with new clinical trial endpoints for approval, have ...
Dr Arturo Loaiza-Bonilla examines the gap between ivermectin’s lab data and clinical reality, offering a guide to debunking ...
Compared with the recommended 4- to 7-day antibiotic course, a 1-day regimen achieved similar clinical cure rates, with no ...
Positive phase 3 findings may reshape Lyme disease prevention among people with frequent tick exposure across endemic regions ...
Jehovah’s Witnesses now allow members to choose to use their own blood in some procedures, reigniting debate over bloodless ...
The new exoskeleton technology combines biomechanics, sensors, and patient feedback to support gait training and ...
This research may be helpful as primary care providers (PCPs) work with patients in managing blood sugar and cardiovascular ...
A history of adequately treated syphilis before pregnancy is associated with more than a 100-fold increase in congenital syphilis risk.
The reasons for the disparities are not clear, but they point to the complexity of the diagnosis and the different ways ...
Children were more likely to undergo an evaluation if they had public insurance, had a higher BMI, had English as a primary ...
Giredestrant plus everolimus does not increase treatment burden in advanced breast cancer, new safety and patient-reported outcome data from the evERA BC trial show.
There are divided opinions over whether anti-inflammatory drugs should always be used when initiating urate-lowering therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results